| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0003 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |